Home / Field Notes / Case Studies

Three “semaglutide” vials, three different molecules

Blind-testing a grey-market batch, the results weren't what the label claimed.

We received three vials sold as semaglutide from three different sources. Only one contained what the label said.

Blind testing removes the label and the bias with it. Here is what the chromatograms showed.

Two of the three were substantially under-dosed; one contained an unrelated peptide entirely.

Keep reading

Related notes.